Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
2.390
-0.490 (-17.01%)
At close: Sep 5, 2025, 4:00 PM
2.400
+0.010 (0.42%)
After-hours: Sep 5, 2025, 7:53 PM EDT
Applied DNA Sciences Employees
As of September 30, 2024, Applied DNA Sciences had 48 total employees, including 46 full-time and 2 part-time employees. The number of employees decreased by 7 or -12.73% compared to the previous year.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$77,980
Profits / Employee
$847,396
Market Cap
3.09M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 48 | -7 | -12.73% |
Sep 30, 2023 | 55 | -14 | -20.29% |
Sep 30, 2022 | 69 | -32 | -31.68% |
Sep 30, 2021 | 101 | 40 | 65.57% |
Sep 30, 2020 | 61 | 10 | 19.61% |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
APDN News
- 22 days ago - Applied DNA Reports Third Quarter Fiscal 2025 Financial Results - Accesswire
- 6 weeks ago - Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application - Accesswire
- 2 months ago - Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements - Accesswire
- 2 months ago - Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx - Accesswire
- 2 months ago - Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward - Accesswire
- 2 months ago - Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August - Accesswire
- 3 months ago - Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 - Accesswire
- 4 months ago - Applied DNA Reports Second Quarter Fiscal 2025 Financial Results - Accesswire